•Executive Summary o Market Overview •Market Landscape o Market ecosystem o Value chain analysis •Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 •Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition •Customer landscape o Overview •Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o APAC - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography •Drivers, Challenges, and Trends o Market drivers o Volume driver - Demand led growth o Volume driver - Supply led growth o Volume driver - External factors o Volume driver - Demand shift in adjacent markets o Price driver - Inflation o Price driver - Shift from lower to higher-priced units o Market challenges o Market trends •Vendor Landscape o Overview o Landscape disruption •Vendor Analysis o Vendors covered o Market positioning of vendors o AVITA Medical Ltd. o Aroa Biosurgery Ltd. o Eucare Pharmaceuticals Pvt. Ltd. o Integra LifeSciences Corp. o Mallinckrodt Plc o MedSkin Solutions Dr. Suwelack AG o MiMedx Group Inc. o Misonix Inc. o Organogenesis Holdings Inc. o Smith & Nephew Plc •Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations •1.Key Finding 1 •2.Key Finding 2 •3.Key Finding 3 •4.Key Finding 5 •5.Key Finding 6 •6.Key Finding 7 •7.Market in focus •9.Parent market •12.Market characteristics •14.Offerings of vendors included in the market definition •16.Market segments •21.Global - Market size and forecast 2019 - 2024 ($ million) •22.Global market: Year-over-year growth 2019 - 2024 (%) •23.Five forces analysis 2019 & 2024 •25.Bargaining power of buyers •26.Bargaining power of suppliers •27.Threat of new entrants •28.Threat of substitutes •29.Threat of rivalry •31.Market condition - Five forces 2019 •32.Customer landscape •33.Market share by geography 2019-2024 (%) •34.Geographic comparison •36.North America - Market size and forecast 2019-2024 ($ million) •37.North America - Year-over-year growth 2019-2024 (%) •39.Europe - Market size and forecast 2019-2024 ($ million) •40.Europe - Year-over-year growth 2019-2024 (%) •42.APAC - Market size and forecast 2019-2024 ($ million) •43.APAC - Year-over-year growth 2019-2024 (%) •45.ROW - Market size and forecast 2019-2024 ($ million) •46.ROW - Year-over-year growth 2019-2024 (%) •47.Key leading countries •48.Market opportunity by geography ($ million) •49.Impact of drivers and challenges •50.Vendor landscape •52.Landscape disruption •54.Industry risk •56.Vendors covered •58.Market positioning of vendors •60.AVITA Medical Ltd. - Overview •61.AVITA Medical Ltd. - Business segments •62.AVITA Medical Ltd. - Key offerings •63.AVITA Medical Ltd. - Key customers •64.AVITA Medical Ltd. - Segment focus •66.Aroa Biosurgery Ltd. - Overview •67.Aroa Biosurgery Ltd. - Product and service •68.Aroa Biosurgery Ltd. - Key offerings •69.Aroa Biosurgery Ltd. - Key customers •70.Aroa Biosurgery Ltd. - Segment focus •72.Eucare Pharmaceuticals Pvt. Ltd. - Overview •73.Eucare Pharmaceuticals Pvt. Ltd. - Product and service •74.Eucare Pharmaceuticals Pvt. Ltd. - Key offerings •75.Eucare Pharmaceuticals Pvt. Ltd. - Key customers •76.Eucare Pharmaceuticals Pvt. Ltd. - Segment focus •78.Integra LifeSciences Corp. - Overview •79.Integra LifeSciences Corp. - Business segments •80.Integra LifeSciences Corp. - Key offerings •81.Integra LifeSciences Corp. - Key customers •82.Integra LifeSciences Corp. - Segment focus •84.Mallinckrodt Plc - Overview •85.Mallinckrodt Plc - Business segments •86.Mallinckrodt Plc - Key offerings •87.Mallinckrodt Plc - Key customers •88.Mallinckrodt Plc - Segment focus •90.MedSkin Solutions Dr. Suwelack AG - Overview •91.MedSkin Solutions Dr. Suwelack AG - Product and service •92.MedSkin Solutions Dr. Suwelack AG - Key offerings •93.MedSkin Solutions Dr. Suwelack AG - Key customers •94.MedSkin Solutions Dr. Suwelack AG - Segment focus •96.MiMedx Group Inc. - Overview •97.MiMedx Group Inc. - Business segments •98.MiMedx Group Inc. - Key offerings •99.MiMedx Group Inc. - Key customers •100.MiMedx Group Inc. - Segment focus •102.Misonix Inc. - Overview •103.Misonix Inc. - Business segments •104.Misonix Inc. - Key offerings •105.Misonix Inc. - Key customers •106.Misonix Inc. - Segment focus •108.Organogenesis Holdings Inc. - Overview •109.Organogenesis Holdings Inc. - Business segments •110.Organogenesis Holdings Inc. - Key offerings •111.Organogenesis Holdings Inc. - Key customers •112.Organogenesis Holdings Inc. - Segment focus •114.Smith & Nephew Plc - Overview •115.Smith & Nephew Plc - Business segments •116.Smith & Nephew Plc - Key offerings •117.Smith & Nephew Plc - Key customers •118.Smith & Nephew Plc - Segment focus •120.Currency conversion rates for US$ •121.Research Methodology •122.Validation techniques employed for market sizing •123.Information sources •124.List of abbreviations

AVITA Medical Ltd., Aroa Biosurgery Ltd., Eucare Pharmaceuticals Pvt. Ltd., Integra LifeSciences Corp., Mallinckrodt Plc, MedSkin Solutions Dr. Suwelack AG, MiMedx Group Inc., Misonix Inc., Organogenesis Holdings Inc., Smith & Nephew Plc